Anesthesia management of patients undergoing hyperthermic isolated limb perfusion with melphalan for melanoma treatment: an analysis of 17 cases
Main Authors: | Ruschulte, Heiner, Shi, Serena, Tseng, William W, Kolodzie, Kerstin, Crawford, Philip C, Schneider, Darren B, Kashani-Sabet, Mohammed, Minor, David, Apfel, Christian, Leong, Stanley PL |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3726295/ |
Similar Items
-
The pathologic response of resected synovial sarcomas to hyperthermic isolated limb perfusion with melphalan and TNF-α: a comparison with the whole group of resected soft tissue sarcomas
by: Schwindenhammer, Benjamin, et al.
Published: (2013) -
The pharmacokinetic advantages of isolated limb perfusion with melphalan for malignant melanoma.
by: Scott, R. N., et al.
Published: (1992) -
Regional Therapy for Recurrent Metastatic Melanoma Confined to the Extremity: Hyperthermic Isolated Limb Perfusion vs. Isolated Limb Infusion
by: Reintgen, Michael, et al.
Published: (2010) -
Melphalan tissue concentrations in patients treated with regional isolated perfusion for melanoma of the lower limb.
by: Klaase, J. M., et al.
Published: (1994) -
TNF-alpha and melphalan-based isolated limb perfusion: no evidence supporting the early destruction of tumour vasculature
by: Podleska, L E, et al.
Published: (2015)